mRNA vaccine development for cholangiocarcinoma: a precise pipeline
1Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
3Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou 310003, China
4Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou 310009, China
5Cancer Center, Zhejiang University, Hangzhou 310058, China
收起